Pharvaris N.v. buy BiotechBee
Start price
21.12.22
/
70%
€8.45
Target price
31.12.24
€10.00
Performance (%)
32.54%
End price
24.06.23
€11.20
Summary
This prediction ended on 24.06.23 with a price of €11.20. With a performance of 32.54% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pharvaris N.v. | - | - | - |
iShares Core DAX® | 2.594% | -1.861% | 13.242% |
iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to BiotechBee what are the pros and cons of Pharvaris N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Pharvaris N.v. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Pharvaris N.v.
Buy beendet
Stopped prediction by BiotechBee for Pharvaris N.v.
Pharvaris N.v.
Start price
Target price
Perf. (%)
€19.60
03.09.23
03.09.23
€26.00
31.12.25
31.12.25
-1.53%
05.09.23
05.09.23
Could be very worthwhile Investment >20% year
Pharvaris N.v.
Start price
Target price
Perf. (%)
€17.80
30.08.23
30.08.23
€25.00
31.12.25
31.12.25
10.11%
03.09.23
03.09.23
Could be very worthwhile Investment >20% year